Equillium Bio (EQ): Future Price to Earnings
Equillium, Inc. (EQ) attracts leading immunologists through stock option programs and scientific prestige. The trend of the company's forward P/E ratio visualizes market expectations, where the value 0.00 represents the current metric. Business stability is ensured by CD6 antibody patents under strict FDA control, as well as a modern certified laboratory base for conducting preclinical trials.
Summary analytical data breakdowns for Equillium Bio (EQ)
- stock value and consensus price forecast:
- stock exchange capitalization data:
- balance sheet equity data:
- issuer credit burden and liquidity indicators:
- financial results and valuation multiples details:
EQ - Net Financial Result|Expected Profit Equillium, Inc.|EQ - Price to Earnings Ratio|Future Price to Earnings Equillium, Inc.|EQ - Price/Earnings to Growth Ratio|EV/EBITDA Multiple Equillium Inc|EQ - Operating income before deduction of amortization|Net earnings per share for the last 12 months Equillium|EQ - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months equilliumbio.com|EQ - Net earnings per share growth this year|Expected earnings per share growth for next year Equillium, Inc.
- sales volume and revenue indicators:
Analysis of all company metrics:EQ Equillium
Fundamental asset selection requires aligning market capitalization with projected business efficiency to exclude overvalued securities. The current value of 0.00 reflects the expected cost per unit of profit, which allows for an assessment of the investment attractiveness of Equillium, Inc. (EQ) against the backdrop of implementing robotic systems in preclinical research via the company's future price-to-earnings ratio.
Competitor analysis
Future Price to Earnings argenx (ARGX)|Projected Price to Earnings BioNTech Inc. BNTX|Future Price to Earnings abivax.com ABVX|ADMA - Projected Price to Earnings|PTGX: Projected Price to Earnings|IMVT - Forward P/E Multiple|Kiniksa (KNSA) - Future Price to Earnings|Price to Future Earnings Ratio GRFS|ADPT (Adaptive Biotechnologies Corp) - Forward P/E Multiple|Projected Price to Earnings Ratio Celldex Corp CLDX|Forward P/E Multiple AUPH|BCRX - Projected Price to Earnings Ratio|Future Price to Earnings Vera Therapeutics VERA|Forward Price to Earnings Multiple Dianthus Therapeutics Inc|PHVS: Projected Price to Earnings|ABCL - Forward P/E Multiple|TRML: Forward P/E Multiple|PGEN - Market Cap to Projected Earnings|Future Price to Earnings Pharming Group|Future Price to Earnings NKTR|Future Price to Earnings Upstream Bio Corp (UPB)|Future Price to Earnings ZBIO (Zenas Corp)|Forward P/E Multiple IMNM (Immunome, Inc.)|Market Cap to Projected Earnings gossamerbio.com (GOSS)|KALV: Projected Price to Earnings|SEPN - Forward P/E Multiple|Pieris Pharmaceuticals Inc (PVLA) - Future Price to Earnings|Projected Price to Earnings Savara Pharma|Projected Price to Earnings RIGL|ANAB: Future Price to Earnings Multiple|Forward P/E Multiple ATXS|Market Cap to Projected Earnings enGene Holdings Inc|Future Price to Earnings RAPT Therapeutics, Inc. RAPT|JBIO: Price to Future Earnings Ratio|Aclaris Therapeutics - Forward P/E Multiple|kyvernatx.com (KYTX) - Projected Price to Earnings|TLSA (Tiziana Life Sciences Ltd) - Projected Price to Earnings|CABA - Market Cap to Projected Earnings|VTYX (Ventyx Bio) - Forward P/E Multiple|Projected Price to Earnings Ratio Theratechnologies, Inc THTX|Future Price to Earnings Avalo Therapeutics, Inc (AVTX)|eledon.com (ELDN) - Forward Price to Earnings Multiple|Future Price to Earnings Agenus Inc. AGEN|CLYM (Climb Bio Inc.) - Price to Expected Earnings Ratio|Zura Bio Limited - Forward P/E Multiple|Future Price to Earnings Multiple ATYR (aTyr Pharmaceuticals)|ADAG: Forward P/E Multiple|Ikena Oncology (IMA) - Forward P/E Multiple|Future Price to Earnings Shattuck Labs Inc|CNTB: Future Price to Earnings Multiple|Future Price to Earnings Immunic, Inc. (IMUX)|Projected Price to Earnings atarabio.com ATRA|Forward P/E Multiple IFRX (InflaRx)|Forward P/E Multiple x4pharma.com XFOR|ACET: Projected Price to Earnings|Future Price to Earnings Multiple CELU (Celularity Inc.)|INMB: Forward P/E Multiple|BRNS - Market Cap to Projected Earnings|Future Price to Earnings Kezar Life Sciences|Projected Price to Earnings sabbiotherapeutics.com (SABS)|Future Price to Earnings Akari Therapeutics Plc (AKTX)|Projected Price to Earnings enlivex.com ENLV|Q32 Bio - Projected Price to Earnings|Forward P/E Multiple GeoVax Corp GOVX|EDSA - Future Price to Earnings|IBIO (ibioinc.com) - Price to Future Earnings Ratio|CARM: Forward P/E Multiple|Projected Price to Earnings Ratio XTL Biopharmaceuticals Ltd (XTLB)|BOLT (Bolt Biotherapeutics Inc.) - Forward P/E Multiple|Projected Price to Earnings Ratio HCW Biologics Inc HCWB|Future Price to Earnings Aptevo Therapeutics (APVO)|AIM ImmunoTech, Inc. (AIM) - Forward Price to Earnings Multiple|Aditxt, Inc. - Projected Price to Earnings|Forward P/E Multiple GRI Bio Inc GRI|XORTX - Forward P/E Multiple|Market Cap to Projected Earnings Vyome Therapeutics HIND|Revelation Biosciences (REVB) - Future Price to Earnings|INDP (indaptusrx.com) - Future Price to Earnings|Future Price to Earnings Scinai Immunotherapeutics Ltd.|Future Price to Earnings CALI|Forward P/E Multiple AFMD|Market Cap to Projected Earnings allakos.com|HOOKIPA Pharma - Projected Price to Earnings|Forward P/E Multiple IGM Biosciences Inc. IGMS|ITOS - Future Price to Earnings|Ocean Biomedical Inc (OCEA) - Projected Price to Earnings|TCBP (TC BioPharm (Holdings) PLC) - Projected Price to Earnings|Third Harmonic Bio Inc - Future Price to Earnings Multiple
